4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-035475
Chairman and CEO bought 6,200 shares at an average $1.70 ($10,548)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-06-08 | Purchase | +2,700 | $1.69 | $4,563 | 10,659,893 | D |
| Niihara Yutaka Chairman and CEO | 2020-06-09 | Purchase | +3,500 | $1.71 | $5,985 | 10,663,393 | D |
| Open-market purchases · 6,200 sh · avg $1.70 · $10,548 | |||||||
Loading xslF345X03/doc4.xml…